Supportive evidence for reduced expression of GNB1L in schizophrenia

Schizophrenia Bulletin

Volumn 36, Issue 4, 2010, Pages 756-765

  Ishiguro, Hiroki ^b   Koga, Minori ^a,b   Horiuchi, Yasue ^a,b   Noguchi, Emiko ^a   Morikawa, Miyuki ^a   Suzuki, Yoshimi ^a   Arai, Makoto ^c   Niizato, Kazuhiro ^d   Iritani, Shyuji ^d   Itokawa, Masanari ^b,d   Inada, Toshiya ^e   Iwata, Nakao ^f   Ozaki, Norio ^g   Ujike, Hiroshi ^h   Kunugi, Hiroshi ⁱ   Sasaki, Tsukasa ^j   Takahashi, Makoto ^k   Watanabe, Yuichiro ^k   Someya, Toshiyuki ^k   Kakita, Akiyoshi ^l   Takahashi, Hitoshi ^l   Nawa, Hiroyuki ^l   Arinami, Tadao ^a,b   more..

^a UNIVERSITY OF TSUKUBA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^e SEIWA HOSPITAL   (Japan)

^f FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h OKAYAMA UNIVERSITY   (Japan)

ⁱ NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^j UNIVERSITY OF TOKYO   (Japan)

^k NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^l NIIGATA UNIVERSITY   (Japan)

more..

Author keywords

22q11DS; Haloperidol; Postmortem brain; Prefrontal cortex

Indexed keywords

HALOPERIDOL; GNB1L PROTEIN, HUMAN; SIGNAL PEPTIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; GENE; GENE EXPRESSION; GENE LOCATION; GENETIC ANALYSIS; GNB1L GENE; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; AGED; AUSTRALIA; CHROMOSOME 22; CHROMOSOME DELETION; COMPARATIVE STUDY; CULTURAL FACTOR; FEMALE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETICS; HOMOZYGOTE; JAPAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PREFRONTAL CORTEX; PSYCHOLOGY; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AUSTRALIA; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; CROSS-CULTURAL COMPARISON; FEMALE; GENE EXPRESSION; GENETIC TESTING; GENOME-WIDE ASSOCIATION STUDY; HOMOZYGOTE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 77958180925     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbn160     Document Type: Article

References (36)

1. Bassett AS, Chow EW. 22q11 deletion syndrome: a geneticsubtype of schizophrenia. Biol Psychiatry. 1999;46:882-891.
2. Karayiorgou M, Gogos JA. The molecular genetics of the22q11-associated schizophrenia. Brain Res Mol Brain Res.2004;132:95-104.
3. Funke B, Edelmann L, McCain N, et al. Der(22) syndromeand velo-cardio-facial syndrome/DiGeorge syndrome sharea 1.5-Mb region of overlap on chromosome 22q11. Am JHum Genet. 1999;64:747-758.
4. Shaikh TH, Kurahashi H, Saitta SC, et al. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome:genomic organization and deletion endpoint analysis. Hum Mol Genet. 2000;9:489-501.
5. Yagi H, Furutani Y, Hamada H, et al. Role of TBX1 in humandel22q11.2 syndrome. Lancet. 2003;362:1366-1373.
6. Stoller JZ, Epstein JA. Identification of a novel nuclear localizationsignal in Tbx1 that is deleted in DiGeorge syndromepatients harboring the 1223delC mutation. Hum Mol Genet.2005;14:885-892.
7. Merscher S, Funke B, Epstein JA, et al. TBX1 is responsiblefor cardiovascular defects in velo-cardio-facial/DiGeorge syndrome.Cell. 2001;104:619-629.
8. Lindsay EA, Vitelli F, Su H, et al. Tbx1 haploinsufficieny inthe DiGeorge syndrome region causes aortic arch defects inmice. Nature. 2001;410:97-101.
9. Paylor R, Glaser B, Mupo A, et al. Tbx1 haploinsufficiency islinked to behavioral disorders in mice and humans: implicationsfor 22q11 deletion syndrome. Proc Natl Acad Sci U SA. 2006;103:7729-7734.
10. Takase K, Ohtsuki T, Migita O, et al. Association of ZNF74gene genotypes with age-at-onset of schizophrenia. Schizophr Res. 2001;52:161-165.
11. Shifman S, Levit A, Chen ML, et al. A complete genetic associationscan of the 22q11 deletion region and functional evidencereveal an association between DGCR2 andschizophrenia. Hum Genet. 2006;120:160-170.
12. Wang H, Duan S, Du J, et al. Transmission disequilibriumtest provides evidence of association between promoter polymorphismsin 22q11 gene DGCR14 and schizophrenia.J Neural Transm. 2006;113:1551-1561.
13. Jacquet H, Raux G, Thibaut F, et al. PRODH mutations andhyperprolinemia in a subset of schizophrenic patients. Hum Mol Genet. 2002;11:2243-2249.
14. Mukai J, Liu H, Burt RA, et al. Evidence that the gene encodingZDHHC8 contributes to the risk of schizophrenia. NatGenet. 2004;36:725-731.
15. Bray NJ, Buckland PR, Williams NM, et al. A haplotype implicatedin schizophrenia susceptibility is associated with reducedCOMT expression in human brain. Am J HumGenet. 2003;73:152-161.
16. Dempster EL, Mill J, Craig IW, Collier DA. The quantificationof COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression. BMC MedGenet. 2006;7:10.
17. Nicodemus KK, Kolachana BS, Vakkalanka R, et al. Evidencefor statistical epistasis between catechol-O-methyltransferase(COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. HumGenet. 2007;120:889-906.
18. Shifman S, Bronstein M, Sternfeld M, et al. A highly significantassociation between a COMT haplotype and schizophrenia.Am J Hum Genet. 2002;71:1296-1302.
19. Sun ZY, Wei J, Xie L, et al. The CLDN5 locus may be involvedin the vulnerability to schizophrenia. Eur Psychiatry.2004;19:354-357. (Pubitemid 39207962)
20. Ye L, Sun Z, Xie L, et al. Further study of a genetic associationbetween the CLDN5 locus and schizophrenia. Schizophr Res. 2005;75:139-141.
21. Faul T, Gawlik M, Bauer M, et al. ZDHHC8 as a candidategene for schizophrenia: analysis of a putative functionalintronic marker in case-control and family-based associationstudies. BMC Psychiatry. 2005;5:35.
22. Glaser B, Moskvina V, Kirov G, et al. Analysis of ProDH, COMT and ZDHHC8 risk variants does not support individualor interactive effects on schizophrenia susceptibility.Schizophr Res. 2006;87:21-27.
23. Li D, He L. Association study of the G-protein signaling 4(RGS4) and proline dehydrogenase (PRODH) genes withschizophrenia: a meta-analysis. Eur J Hum Genet. 2006;14:1130-1135.
24. Munafo MR, Bowes L, Clark TG, Flint J. Lack of associationof the COMT (Val158/108 Met) gene and schizophrenia:a meta-analysis of case-control studies. Mol Psychiatry. 2005;10:765-770.
25. Hiroi N, Zhu H, Lee M, et al. A 200-kb region of humanchromosome 22q11.2 confers antipsychotic-responsive behavioralabnormalities in mice. Proc Natl Acad Sci U S A. 2005;102:19132-19137.
26. Williams NM, Glaser B, Norton N, et al. Strong evidencethat GNB1L is associated with schizophrenia. Hum Mol Genet. 2008;17:555-566.
27. Centonze D, Usiello A, Costa C, et al. Chronic haloperidolpromotes corticostriatal long-term potentiation by targetingdopamine D2L receptors. J Neurosci. 2004;24:8214-8222.
28. Leite JV, Guimaraes FS, Moreira FA. Aripiprazole, an atypicalantipsychotic, prevents the motor hyperactivity inducedby psychotomimetics and psychostimulants in mice. Eur JPharmacol. 2008;578:222-227.
29. Duncan GE, Moy SS, Lieberman JA, Koller BH. Effects of haloperidol, clozapine, and quetiapine on sensorimotor gatingin a genetic model of reduced NMDA receptor function.Psychopharmacology (Berl). 2006;184:190-200.
30. Narayan S, Kass KE, Thomas EA.Chronichaloperidol treatmentresults in a decrease in the expression of myelin/oligodendrocyterelatedgenes in themouse brain. J Neurosci Res. 2007;85:757-765.
31. Nagai T, Murai R, Matsui K, et al. Aripiprazole amelioratesphencyclidine- induced impairment of recognition memorythrough dopamine D(1) and serotonin 5-HT (1A) receptors.Psychopharmacology (Berl). 2008 First published ib August6, 2008, DOI:10.1007/s00213-008-1240-6.
32. Funke B, Epstein JA, Kochilas LK, et al. Mice overexpressinggenes from the 22q11 region deleted in velo-cardio-facialsyndrome/DiGeorge syndrome have middle and inner eardefects. Hum Mol Genet. 2001;10:2549-2556.
33. Monks SA, Leonardson A, Zhu H, et al. Genetic inheritanceof gene expression in human cell lines. Am J Hum Genet.2004;75:1094-1105.
34. Morley M, Molony CM, Weber TM, et al. Genetic analysis of genome-wide variation in human gene expression. Nature.2004;430:743-747.
35. Pitto L, Ripoli A, Cremisi F, Simili M, Rainaldi G. Micro- RNA(interference) networks are embedded in the gene regulatorynetworks. Cell Cycle. 2008;7(16):2458-2461.
36. Bray NJ, Holmans PA, van den Bree MB, et al. Cis- andtrans-loci influence expression of the schizophrenia susceptibilitygene DTNBP1. Hum Mol Genet. 2008;17:1169-11